TrialClinical drug investigation2024

Single‑Dose Pharmacokinetics and Safety of the Oral Galectin‑3 Inhibitor, Selvigaltin (GB1211), in Participants with Hepatic Impairment.

Vassilios Aslanis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.